New Delhi: Union Health Minister Harsh Vardhan said that late-stage clinical trials of intranasal COVID-19 vaccines are expected to be pursued by Serum Institute of India and Bharat Biotech once they receive regulatory approval.
The minister also said the late-stage trial usually involves 30,000 to 40,000 participants. Currently, the vaccines currently in Phase 3 trials are administered by injection, as per the World Health Organization (WHO).
According to India’s Dr Reddy’s Laboratories Ltd and the Russian Direct Investment Fund (RDIF) on Saturday, they have received renewed approval for performing late-stage clinical trials in India of the Russian COVID-19 vaccine.
In the past 24 hours, India’s coronavirus infections surged by another 61,871, data released on Sunday showed.
Mumbai: Bollywood’s 'Mr Perfectionist' Aamir Khan has been contemplating quitting the industry for quite some…
Balasore: Two minor girls reportedly drowned while trying to collect miniature boats from a pond…
Ahmedabad: The Central government’s resolve to clamp down on illegal drug trafficking in the country resulted…
Bhubaneswar: The School of Hotel Management, faculty of hospitality and tourism management of Siksha ‘O’…
New Delhi: Clouds of uncertainty continue to hover over the Champions Trophy, which is scheduled to…
Bhubaneswar: Odisha Chief Minister Mohan Charan Majhi on Friday laid foundation stone for development projects…
Mumbai: Abbas-Mustan’s 1993 film ‘Baazigar’ had played a major role in shaping Shah Rukh Khan’s…
Cuttack: Odisha gave their supporters at Barabati Stadium some really nervous moments here on Friday…